The Drug Enforcement Administration is suing the Colorado State Board of Pharmacy, demanding it share patient information from its prescription drug monitoring program, according to The Colorado Sun.
The DEA reduced opioid production by 25% in 2017, 20% in 2018 and another 10% in 2019. After mass shortages of injectable medications nationwide, the agency admits that less than 1% of production drugs are diverted into the black market. With no correlation between production and misuse, the agency intends to further reduce supplies.
DEA officials announced on November 7, 2019, a Fentanyl bust in cooperation with Chinese officials which netted enough of the substance to kill 6 million people. 9 Chinese citizens were arrested and a Chinese court imposed a suspended death sentence on one and life imprisonment for the remaining eight, all pleaded guilty to smuggling fentanyl into the U.S.
The Opioid Buyer Drill Down Report has more than 186 Million records and allows searching by year, drug types, business types, States and Cities.
Numbers are reported as Average Monthly Scripts based on daily MME dosages of 30, 50, 90, 120, 150. For some non-cancer patients, dosages run as high as 350 MME per day, more for patients with cancer. Meaning, the actual number of scripts as reported here, are lower.
This report covers all US States from 2006 – 2012 and provides what would be the average population per script written for age groups 15 – 85 and dosage levels 50-150 MME.
Share the News 3 1 4SharesLikeBy R Carter When trying to define accountability or the lack thereof, to which groups played a role in how the opioid overdose problem grew to such proportions, I’ve often used this analogy. The Analogy Image the Federal Government providing funds to build an interstate highway…
Aggregated DEA pill data is reported as a ratio of state population to average monthly scripts at selected dosage amounts.
The DEA has proposed new controls for three precursor chemicals used to illicitly manufacture fentanyl.
The DEA searched and shut down a dozen Florida pharmacies this week as part of “Operation Cazador,” seizing roughly 200,000 opioid pills, more than 35 weapons and about $3.3 million in assets, NBC News reported Friday.
The U.S. Drug Enforcement Administration is proposing to reduce the manufacturing of five Schedule II opioid controlled substances in the United States next year